Xiaoling Fang Selected Research

Therapeutic Uses

1/2022	Identification of the immune subtype of ovarian cancer patients by integrated analyses of transcriptome and single-cell sequencing data.
1/2020	Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer.
1/2015	The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment.
7/2014	Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis.
11/2012	Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoling Fang Research Topics

Disease

53	Neoplasms (Cancer) 10/2023 - 06/2007
18	Endometriosis 03/2024 - 06/2002
8	Glioma (Gliomas) 04/2018 - 06/2011
6	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 12/2010
5	Inflammation (Inflammations) 03/2024 - 12/2016
4	Breast Neoplasms (Breast Cancer) 04/2016 - 06/2007
3	Infertility (Sterility) 10/2022 - 11/2020
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 04/2018
2	Endometrial Neoplasms (Endometrial Cancer) 04/2021 - 11/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 08/2015
2	Carcinoma (Carcinomatosis) 04/2018 - 06/2012
2	Melanoma (Melanoma, Malignant) 01/2014 - 09/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2013 - 08/2010
2	Adenocarcinoma of Lung 08/2010 - 07/2009
1	Brain Injuries (Brain Injury) 02/2024
1	Brain Diseases (Brain Disorder) 02/2024
1	Cysts 11/2023
1	Colorectal Neoplasms (Colorectal Cancer) 05/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Memory Disorders (Memory Loss) 01/2023
1	Cognitive Dysfunction 01/2023
1	Pterygium 12/2022
1	Myocardial Infarction 09/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2022
1	Congenital Heart Defects (Congenital Heart Defect) 01/2022
1	Infections 07/2021
1	Diabetes Mellitus 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Carcinogenesis 01/2021
1	Hypertension (High Blood Pressure) 01/2021

Drug/Important Bio-Agent (IBA)

22	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 06/2007
21	MicellesIBA 01/2020 - 06/2007
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2011
12	Poloxamer (Poloxamer 407)IBA 04/2016 - 06/2007
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2016
8	Peptides (Polypeptides)IBA 01/2019 - 12/2011
7	UCON 50-HB-5100 (F127)IBA 01/2015 - 07/2009
6	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2016
6	LigandsIBA 01/2019 - 12/2011
6	IntegrinsIBA 01/2016 - 12/2011
6	polytrimethylene carbonateIBA 05/2014 - 11/2011
5	Therapeutic UsesIBA 01/2022 - 11/2012
5	cyclic arginine-glycine-aspartic acid peptideIBA 01/2016 - 12/2011
4	Messenger RNA (mRNA)IBA 09/2022 - 01/2020
4	Circular RNAIBA 12/2021 - 12/2018
4	Small Interfering RNA (siRNA)IBA 11/2020 - 03/2015
4	PolymersIBA 01/2020 - 05/2014
4	Folic Acid (Vitamin M)FDA LinkGeneric 01/2015 - 06/2007
4	Ethylene Glycol (Monoethylene Glycol)IBA 05/2014 - 12/2010
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2021
3	Long Noncoding RNAIBA 01/2021 - 01/2020
3	Competitive Endogenous RNAIBA 01/2021 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2021 - 11/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 07/2015
3	Nanoparticle Drug Delivery SystemIBA 07/2015 - 06/2011
3	pluronic block copolymer P123IBA 02/2013 - 08/2010
3	pluronic P105IBA 01/2013 - 06/2012
2	LipidsIBA 10/2023 - 12/2016
2	EnzymesIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2020
2	CreatinineIBA 01/2021 - 08/2011
2	Cadherins (E-Cadherin)IBA 01/2020 - 04/2018
2	CarbohydratesIBA 01/2019 - 01/2013
2	poly(propyleneimine)IBA 04/2016 - 03/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 08/2013
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 05/2014 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 02/2013 - 01/2013
2	LDL Receptors (LDL Receptor)IBA 11/2012 - 06/2011
2	caprolactoneIBA 06/2011 - 12/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2024
1	ResveratrolIBA 11/2023
1	Hormones (Hormone)IBA 10/2023
1	Metformin (Glucophage)FDA LinkGeneric 10/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2023
1	AdipokinesIBA 10/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	Butyric Acid (Butanoic Acid)IBA 01/2023
1	CateninsIBA 04/2022
1	NucleotidesIBA 01/2022
1	Estrogen ReceptorsIBA 12/2021
1	Protein Inhibitors of Activated STATIBA 04/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2021
1	AlbuminsIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Activating Transcription Factor 3IBA 01/2021
1	FructoseIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021

Therapy/Procedure

17	Therapeutics 10/2023 - 09/2010
8	Drug Therapy (Chemotherapy) 01/2020 - 06/2007
2	Slit Lamp 12/2022 - 03/2020
2	Lymph Node Excision (Lymph Node Dissection) 07/2021 - 01/2021
2	Intravenous Administration 07/2014 - 04/2011
1	Complementary Therapies (Alternative Medicine) 01/2023
1	Electroacupuncture 01/2023
1	Immunotherapy 01/2022
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2022